Screening of Open Global Health Library for Dengue Drug Discovery

Severe dengue, known as dengue hemorrhagic fever or dengue shock syndrome, is a leading cause of hospitalization and death in Asia and Latin America. There is no specific treatment for the disease. Dr. Tedjo Sasmono at the Eijkman Institute for Molecular Biology will screen the Open Global Health Library of Merck KGaA, Darmstadt, Germany to identify compounds that target pathways that are disrupted in severe dengue.